research use only
Cat.No.S8003
| Related Targets | EGFR VEGFR PDGFR FGFR c-Met Src MEK CSF-1R FLT3 HER2 |
|---|---|
| Other IGF-1R Inhibitors | Linsitinib (OSI-906) BMS-536924 NVP-AEW541 BMS-754807 Picropodophyllin (AXL1717) GSK1904529A AG-1024 NVP-ADW742 NT157 Ginsenoside Rg5 |
|
In vitro |
DMSO
: 32 mg/mL
(93.62 mM)
Water : Insoluble Ethanol : Insoluble |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
| Molecular Weight | 341.79 | Formula | C18H16ClN3O2 |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 196868-63-0 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | N/A | Smiles | CC1=NC2=CC=CC=C2C(=C1)NC(=O)NC3=C(C=CC(=C3)Cl)OC | ||
| Targets/IC50/Ki |
IGF-1R
<1 μM
|
|---|---|
| In vitro |
PQ 401 is an IGF-1R inhibitor and inhibits autophosphorylation of the IGF-IR kinase domain at concentrations <100 nM, with an IC50 <1μM. This compound significantly reduced proliferation of MCF-7 cells with IC50 of 8 μM. It also inhibits growth of MCNeuA cells with IC50 of 15 μM. This inhibitor blocks the IGF-I-mediated antiapoptotic pathway in MCF-7 cells. It increases caspase-mediated apoptotic activity in MCF-7 cells.
|
| Kinase Assay |
IGF-IR Peptide Autophosphorylation
|
|
One microgram of constitutively active IGF-IR kinase domain peptide is incubated +/− varying concentrations of PQ 401 in 2% DMSO in 40 mM Tris (pH 7.4), 80 μM EGTA, 0.25% 2-mercaptoethanol, 80 μM Na3VO4, 10 mM MgCl2, and 2 mM MnCl2 for 20 minutes. ATP is then added at a final concentration of 20 μM. Autophosphorylation of the kinase domain peptide is allowed to occur for 20 minutes at 22℃. The reaction is stopped by the addition of SDS-reducing buffer and the samples are run on SDS-PAGE. Following transfer to nitrocellulose membrane, peptide autophosphorylation is determined by Western blotting employing an antibody against phosphotyrosine (PY20).
|
|
| In vivo |
PQ 401 (50 mg/Kg, 100 mg/Kg) significantly inhibits MCNeuA tumor growth in a dose-dependent manner.
|
References |
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.